Short Interest in Heart Test Laboratories, Inc. (NASDAQ:HSCS) Expands By 6.1%

Heart Test Laboratories, Inc. (NASDAQ:HSCS) was the target of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 31,200 shares, a growth of 6.1% from the December 31st total of 29,400 shares. Approximately 3.8% of the shares of the company are short sold. Based on an average daily volume of 42,900 shares, the days-to-cover ratio is presently 0.7 days.

Analysts Set New Price Targets

Separately, Maxim Group restated a “buy” rating and set a $12.00 price target on shares of Heart Test Laboratories in a report on Wednesday, December 18th.

Heart Test Laboratories Stock Performance

HSCS stock opened at $3.23 on Tuesday. The business’s fifty day moving average is $3.55 and its 200-day moving average is $3.45. The company has a market cap of $3.17 million, a P/E ratio of -0.41 and a beta of 2.88. The company has a quick ratio of 1.52, a current ratio of 1.72 and a debt-to-equity ratio of 0.01. Heart Test Laboratories has a twelve month low of $2.36 and a twelve month high of $18.50.

Heart Test Laboratories (NASDAQ:HSCS) last released its quarterly earnings results on Monday, December 16th. The company reported ($2.27) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.30) by $0.03. During the same quarter last year, the company earned ($15.92) earnings per share. Equities research analysts forecast that Heart Test Laboratories will post -9.82 EPS for the current year.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.